Lexatumumab, a targeted antibody, represents significant potential in the battle against tumor conditions. This new drug uniquely attaches to lthe HER3 molecule, which is frequently overexpressed in various tumoral https://bookmark-dofollow.com/story28257209/lexatumumab-a-promising-therapy-for-tumors